Felix Rey | Head of Structures Institut Pasteur | France
DC Pre-congress WS day April 2 @ 09:00
Advances in using structure-based knowledge for smarter vaccine designs
Structure-based vaccines are designed on the rationale that protective epitopes should be sufficient to induce immune responses and provide protection against pathogens, with multiple epitopes inducing a higher immune response. Structure-based vaccines have become a much-anticipated field over the years with increasingly more preclinical and clinical staged developments. This workshop focuses on recent advances and their application in providing protection against infectious diseases.
Progress in Stabilized Pre-fusion Glycoprotein Vaccines for Paramyxoviruses & HIV-1
Using structural based vaccine design to target flavivirus infections: Zika and Dengue
Dr Peter Kwong / Advances in using structure-based knowledge for smarter vaccine designs
Dr Peter Kwong, Chief, Structural Biology Section, NIH
Dr. Kwong is Chief of the Structural Biology Section at the Vaccine Research Center at the National Institutes of Health. He is internationally recognized for his work defining structural aspects of the HIV-1 envelope glycoproteins and their interactions with antibodies. For the last several...
Dr Hans Langedijk / Advances in using structure-based knowledge for smarter vaccine designs
Dr Hans Langedijk, Director of Subunit Vaccine Design, Janssen Vaccines & Prevention B.V.
Hans (JPM) Langedijk currently holds the position of Scientific Director of the Subunit Vaccine Design team, part of Viral Vaccines department at Janssen Vaccines and Prevention. He has set up a protein chemistry group and is responsible for the design and development of novel protein vaccine...